Intrinsic Edge Capital Management LLC Corcept Therapeutics Inc Transaction History
Intrinsic Edge Capital Management LLC
- $782 Million
- Q3 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 186,150 shares of CORT stock, worth $9.77 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
186,150
Previous 181,020
2.83%
Holding current value
$9.77 Million
Previous $5.88 Million
46.42%
% of portfolio
1.1%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$868 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$525 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$434 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$342 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$200 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.62B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...